Table 1

Demographic, clinical and verbal fluency task performance characteristics of study participants at baseline

CharacteristicGroup, mean ± SDStatistical analysis*Post hoc statistical analysis
CHR-NR (n = 73)CHR-R (n = 23)Control (n = 178)F or t or χ2p valueCHR-NR – CHR-RCHR-NR – controlCHR-R – control
Sex, M/F21/5210/1372/1063.380.184
Age, yr20.5 ± 3.819.5 ± 3.923.4 ± 4.517.2< 0.0010.596< 0.001< 0.001
IQ106.0 ± 13.6109.7 ± 14.9111.6 ± 12.15.070.0070.4400.0050.777
Education, yr12.6 ± 1.912.1 ± 1.914.2 ± 1.632.69< 0.0010.443< 0.001< 0.001
Duration of follow-up, mo32.1 ± 23.942.8 ± 24.16−1.860.071
SOPS
 Positive symptoms10.3 ± 3.47.9 ± 3.82.680.011
 Negative symptoms14.2 ± 5.712.1 ± 6.31.420.164
 Disorganization4.8 ± 2.53.5 ± 1.43.030.003
 General symptoms7.8 ± 3.78.0 ± 3.1−0.210.833
GAF51.2 ± 7.553.0 ± 8.4−0.920.362
Exposure to antipsychotics5.1 ± 3.43.2 ± 2.62.850.006
Verbal fluency task performance measures
 No. of words produced19.4 ± 5.521.8 ± 4.921.4 ± 4.75.130.0070.0910.0060.936
 Average semantic cluster size2.7 ± 0.63.1 ± 0.72.7 ± 0.64.930.0080.0130.9990.006
 Maximum semantic cluster size6.9 ± 2.48.3 ± 3.46.8 ± 2.24.060.0180.0350.9740.014
  • CHR-NR = participants at clinical high risk for psychosis who did not remit; CHR-R = participants at clinical high risk for psychosis who later remitted; F = female; GAF = Global Assessment of Functioning; IQ = intelligence quotient; M = male; SD = standard deviation; SOPS = Scale of Prodromal Symptoms.

  • * Analysis of variance, independent t test or Welch t test if the variances were not equal; χ2 analysis or Fisher exact test for categorical data.

  • Post hoc Tukey honestly significant difference adjusted p value for variables that showed significant between-group difference in analysis of variance.

  • Mean olanzapine-equivalent dose of antipsychotics prescribed during follow-up.